Sign Up to like & get
recommendations!
0
Published in 2018 at "Kidney International Reports"
DOI: 10.1016/j.ekir.2017.10.009
Abstract: Introduction Complications associated with insulin treatment for hyperkalemia are serious and common. We hypothesize that, in chronic kidney disease (CKD) and end-stage renal disease (ESRD), giving 5 units instead of 10 units of i.v. regular…
read more here.
Keywords:
insulin;
treatment;
hypoglycemia;
protocol ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Expert Review of Clinical Pharmacology"
DOI: 10.1080/17512433.2020.1774363
Abstract: ABSTRACT Introduction Hyperkalemia is a chronic and life-threatening electrolyte disorder that affects millions of patients around the world with decreased kidney function, hypertension, and heart failure. Recently newer oral potassium-binding agents have been approved for…
read more here.
Keywords:
potassium;
use;
patiromer;
hyperkalemia ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Journal of Hospital Medicine"
DOI: 10.12788/jhm.3145
Abstract: Hypoglycemia is a serious complication following treatment of hyperkalemia with intravenous insulin. The aims of this study were to determine the incidence of hypoglycemia (⩽3.9 mmol/l, 70 mg/dL) and severe hypoglycemia (
read more here.
Keywords:
treatment;
following treatment;
hypoglycemia;
treatment hyperkalemia ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Drug, Healthcare and Patient Safety"
DOI: 10.2147/dhps.s338579
Abstract: Abstract Hyperkalemia remains one of the most difficult consequences of disease state and treatment for patients with chronic kidney disease, heart failure, and diabetes. Controlling hyperkalemia can be difficult, but has become easier with the…
read more here.
Keywords:
treatment hyperkalemia;
hyperkalemia;
patiromer;
efficacy safety ... See more keywords